![Nucleic acids presenting polymer nanomaterials as vaccine adjuvants - Journal of Materials Chemistry B (RSC Publishing) DOI:10.1039/C9TB01222B Nucleic acids presenting polymer nanomaterials as vaccine adjuvants - Journal of Materials Chemistry B (RSC Publishing) DOI:10.1039/C9TB01222B](https://pubs.rsc.org/image/article/2019/TB/c9tb01222b/c9tb01222b-f2_hi-res.gif)
Nucleic acids presenting polymer nanomaterials as vaccine adjuvants - Journal of Materials Chemistry B (RSC Publishing) DOI:10.1039/C9TB01222B
![Poly‐ICLC preconditioning protects the blood–brain barrier against ischemic injury in vitro through type I interferon signaling - Gesuete - 2012 - Journal of Neurochemistry - Wiley Online Library Poly‐ICLC preconditioning protects the blood–brain barrier against ischemic injury in vitro through type I interferon signaling - Gesuete - 2012 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/16f468d3-c321-413d-822d-7a3667d5c4d3/jnc7946-fig-0004-m.jpg)
Poly‐ICLC preconditioning protects the blood–brain barrier against ischemic injury in vitro through type I interferon signaling - Gesuete - 2012 - Journal of Neurochemistry - Wiley Online Library
![A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02017-2/MediaObjects/13046_2021_2017_Fig1_HTML.png)
A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text
![Protocol schema. Patients received two cycles of poly-ICLC treatment,... | Download Scientific Diagram Protocol schema. Patients received two cycles of poly-ICLC treatment,... | Download Scientific Diagram](https://www.researchgate.net/publication/326024552/figure/fig1/AS:718392709357569@1548289577897/Protocol-schema-Patients-received-two-cycles-of-poly-ICLC-treatment-each-cycle.png)
Protocol schema. Patients received two cycles of poly-ICLC treatment,... | Download Scientific Diagram
![Enhancing the immune stimulatory effects of cetuximab therapy through TLR3 signalling in Epstein-Barr virus (EBV) positive nasopharyngeal carcinoma. - Abstract - Europe PMC Enhancing the immune stimulatory effects of cetuximab therapy through TLR3 signalling in Epstein-Barr virus (EBV) positive nasopharyngeal carcinoma. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6204995/bin/koni-07-11-1500109-g001.jpg)
Enhancing the immune stimulatory effects of cetuximab therapy through TLR3 signalling in Epstein-Barr virus (EBV) positive nasopharyngeal carcinoma. - Abstract - Europe PMC
![Cancers | Free Full-Text | Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events Cancers | Free Full-Text | Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events](https://pub.mdpi-res.com/cancers/cancers-13-02237/article_deploy/html/images/cancers-13-02237-ag-550.jpg?1620348663)
Cancers | Free Full-Text | Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events
![Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration | Journal for ImmunoTherapy of Cancer Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/8/2/e001224/F6.large.jpg)
Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration | Journal for ImmunoTherapy of Cancer
![Frontiers | Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial Frontiers | Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial](https://www.frontiersin.org/files/Articles/432384/fimmu-10-00725-HTML/image_m/fimmu-10-00725-t001.jpg)
Frontiers | Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial
![Cancers | Free Full-Text | Exploratory Study of the Effect of IMA950/Poly- ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients Cancers | Free Full-Text | Exploratory Study of the Effect of IMA950/Poly- ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients](https://www.mdpi.com/cancers/cancers-11-00464/article_deploy/html/images/cancers-11-00464-g001.png)
Cancers | Free Full-Text | Exploratory Study of the Effect of IMA950/Poly- ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients
WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrich
![A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02017-2/MediaObjects/13046_2021_2017_Fig4_HTML.png)
A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text
![JCI - Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population JCI - Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population](https://dm5migu4zj3pb.cloudfront.net/manuscripts/40000/40817/medium/JCI40817.f2.jpg)
JCI - Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population
![Efficacy of 4% articaine vs 2% lidocaine in mandibular and maxillary block and infiltration anaesthesia in patients with irreversible pulpitis: a systematic review and meta-analysis [PeerJ] Efficacy of 4% articaine vs 2% lidocaine in mandibular and maxillary block and infiltration anaesthesia in patients with irreversible pulpitis: a systematic review and meta-analysis [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/12214/1/fig-6-full.png)
Efficacy of 4% articaine vs 2% lidocaine in mandibular and maxillary block and infiltration anaesthesia in patients with irreversible pulpitis: a systematic review and meta-analysis [PeerJ]
![Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-α and IFN-γ dependent manners | SpringerLink Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-α and IFN-γ dependent manners | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00262-010-0876-3/MediaObjects/262_2010_876_Fig4_HTML.gif)
Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-α and IFN-γ dependent manners | SpringerLink
![A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract | Mucosal Immunology A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract | Mucosal Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmi.2015.133/MediaObjects/41385_2016_Article_BFmi2015133_Fig1_HTML.jpg)
A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract | Mucosal Immunology
![Nucleic acid-based drugs for eliciting a host's innate immunity against viral diseases | Nucleic Acid-Based Drugs Nucleic acid-based drugs for eliciting a host's innate immunity against viral diseases | Nucleic Acid-Based Drugs](https://www.futuremedicine.com/cms/10.4155/ebo.13.472/asset/images/medium/figure1.gif)
Nucleic acid-based drugs for eliciting a host's innate immunity against viral diseases | Nucleic Acid-Based Drugs
![In situ Vaccination Followed by Intramuscular poly-ICLC Injections for the Treatment of Hepatocellular Carcinoma in Mouse Models - ScienceDirect In situ Vaccination Followed by Intramuscular poly-ICLC Injections for the Treatment of Hepatocellular Carcinoma in Mouse Models - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661823000026-ga1.jpg)
In situ Vaccination Followed by Intramuscular poly-ICLC Injections for the Treatment of Hepatocellular Carcinoma in Mouse Models - ScienceDirect
![Poly‐ICLC preconditioning protects the blood–brain barrier against ischemic injury in vitro through type I interferon signaling - Gesuete - 2012 - Journal of Neurochemistry - Wiley Online Library Poly‐ICLC preconditioning protects the blood–brain barrier against ischemic injury in vitro through type I interferon signaling - Gesuete - 2012 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/df492a2d-e344-4078-9259-e50682c88334/jnc7946-fig-0002-m.jpg)